Showing results (51-60 of 7,325) with videos related to
Sort By:
Pageof 733
Molecular and Cellular Pharmacology|March 7, 2022
The emerging CDK4/6 inhibitor for breast cancer treatmentM Saeed Sheikh, Siem A SattiJournal of Cell Science|April 11, 2013
Negative regulation of p53 by Ras superfamily protein RBEL1AKi Lui, Jie An, Joanne Montalbano, et al.Current Cancer Drug Targets|July 28, 2026
Corrigendum to: High Glucose and Glucose-derived Intermediates are Linked to Lung Cancer AggressivenessHimani Joshi, Raiyan Satti, M Saeed SheikhMolecular and Cellular Biochemistry|August 1, 2020
Quinovic acid purified from medicinal plant Fagonia indica mediates anticancer effects via death receptor 5Asma Umer Khayam, Harsh Patel, Nicholas A Faiola, et al.Oncogene|April 20, 2002
Endoplasmic reticulum calcium pool depletion-induced apoptosis is coupled with activation of the death receptor 5 pathwayQin He, Dong Ik Lee, Rong Rong, et al.Cancer Biology & Therapy|August 13, 2002
Paclitaxel-induced FasL-independent apoptosis and slow (non-apoptotic) cell deathMikhail V Blagosklonny, Robert Robey, M Saeed Sheikh, et al.Cancer Biology & Therapy|March 13, 2010
Dihydroartemisinin upregulates death receptor 5 expression and cooperates with TRAIL to induce apoptosis in human prostate cancer cellsQin He, Jinxue Shi, Xiao-Ling Shen, et al.Journal of Cancer|November 6, 2023
The oncogenic potential of Rab-like protein 1A (RBEL1A) GTPase: The first review of RBEL1A research with future research directions and challengesKi Lui, Ying Huang, M Saeed Sheikh, et al.Cell Cycle (Georgetown, Tex.)|December 6, 2003
Codon-optimized cloning, expression and characertization of the C-terminal region of human apoptotic protein GADD34 in Escherichia coliPing Yu, Nouri Neamati, Sergey Tarasov, et al.Clinical Trials (London, England)|May 8, 2015
Identifying optimal biomarker combinations for treatment selection through randomized controlled trialsYing HuangPageof 733